IP Library Assignment 024933/0616
Patent Assignment
Reel/Frame 024933/0616

Assignment of Assignor's Interest

Recorded: 2010-09-03 Pages: 35
Assignor
ATHEROGENICS, INC.
Executed: 2009-04-01
Assignee
CRABTREE ACQUISITION CO, LLC
28161 N. KEITH DRIVE, LAKE FOREST, ILLINOIS, 60045
Covered Properties (35)
Monoesters of Probucol for the Treatment of Cardiovascular and Inflammatory Disease
Patent: 6,121,319 →
Application: 09/078,935 →
Compounds and Methods for the Inhibition of the Expression of Vcam-1
Patent: 6,147,250 →
Application: 09/079,213 →
Compounds and Methods for the Inhibition of the Expression of Vcam-1
Patent: 6,548,699 →
Application: 09/370,046 →
Methods and Compositions to Lower Plasma Cholesterol Levels
Patent: 6,887,712 →
Application: 09/436,892 →
Antioxidant Enhancement of Therapy for Hyperproliferative Conditions
Patent: 7,071,158 →
Application: 09/779,086 →
Publication: US 2001/0049349
N-Substituted Dithiocarbamates for the Treatment of Biological Disorders
Patent: 6,747,061 →
Application: 09/815,244 →
Publication: US 2003/0176496
Thioketals and Thioethers for Inhibiting the Expression of Vcam-1
Patent: 6,852,878 →
Application: 09/815,262 →
Publication: US 2002/0016300
Compounds and Methods to Increase Plasma Hdl Cholesterol Levels and Improve Hdl Functionality
Patent: 6,881,860 →
Application: 09/833,407 →
Publication: US 2002/0016364
1, 3-Bis-(Substituted-Phenyl)-2-Propen-1-Ones and Their Use to Treat Vcam-1 Mediated Disorders
Patent: 6,608,101 →
Application: 09/886,348 →
Compounds and Methods for Treating Transplant Rejection
Patent: 6,670,398 →
Application: 10/036,307 →
Publication: US 2002/0156022
Compounds and Methods for the Inhibition of the Expression of Vcam-1
Patent: 6,617,352 →
Application: 10/060,734 →
Publication: US 2002/0177717
Compounds and Methods for the Inhibition of the Expression of Vcam-1
Patent: 6,602,914 →
Application: 10/114,346 →
Publication: US 2002/0169215
Compounds and Methods for the Inhibition of the Expression of Vcam-1
Patent: 7,375,252 →
Application: 10/114,351 →
Publication: US 2002/0193446
Compounds and Methods for the Inhibition of the Expression of Vcam-1
Patent: 6,828,447 →
Application: 10/115,206 →
Publication: US 2002/0188118
Protection Against Oxidative Stress and Inflammation by a Cytoprotective Response Element
Patent: 7,247,714 →
Application: 10/271,429 →
Publication: US 2004/0023233
Chalcone Derivatives and Their Use to Treat Diseases
Patent: 7,094,801 →
Application: 10/324,987 →
Publication: US 2004/0048858
1,3-Bis-(Substituted-Phenyl)-2-Propyn-1-Ones and Their Use to Treat Disorders
Patent: 7,202,247 →
Application: 10/325,087 →
Publication: US 2003/0232877
1,3-Bis-(Substituted-Phenyl)-2-Propen-1-Ones and Their Use to Treat Vcam-1 Mediated Disorders
Patent: 7,078,431 →
Application: 10/443,470 →
Publication: US 2003/0236298
Novel Salt Forms of Poorly Soluble Probucol Esters and Ethers
Patent: 6,960,683 →
Application: 10/619,268 →
Publication: US 2004/0082807
Compounds and Methods for the Inhibition of the Expression of Vcam-1
Patent: 7,189,870 →
Application: 10/647,766 →
Publication: US 2005/0090487
Compounds and Methods for Treating Transplant Rejection
Patent: 7,087,645 →
Application: 10/744,763 →
Publication: US 2004/0138147
Process of Preparing Esters and Ethers of Probucol and Derivatives Thereof
Patent: 7,273,948 →
Application: 10/757,664 →
Publication: US 2004/0204485
Sulfonamide-Substituted Chalcone Derivatives and Their Use to Treat Diseases
Patent: 7,173,129 →
Application: 10/863,115 →
Publication: US 2005/0049236
Compounds and Methods to Increase Plasma Hdl Cholesterol Levels and Improve Hdl Functionality
Patent: 7,183,317 →
Application: 10/886,927 →
Publication: US 2004/0266879
Process of Preparing Esters and Ethers of Probucol and Derivatives Thereof
Patent: 7,294,737 →
Application: 11/111,194 →
Publication: US 2005/0267187
Phenolic Antioxidants for the Treatment of Disorders Including Arthritis, Asthma and Coronary Artery Disease
Patent: 7,271,274 →
Application: 11/111,196 →
Publication: US 2006/0020038
Methods for Treating Diabetic Vascular Diseases
Application: 11/171,847 →
Publication: US 2006/0058268
Novel Salt Forms of Poorly Soluble Probucol Esters and Ethers
Patent: 7,371,895 →
Application: 11/263,821 →
Publication: US 2006/0079713
Methods for reducing platelet activation and for the treatment of thrombotic events
Application: 11/544,845 →
Publication: US 2007/0213303
Process of Preparing Esters and Ethers of Probucol and Derivatives Thereof
Patent: 7,622,604 →
Application: 11/854,939 →
Publication: US 2008/0009642
Methods of Derivatives of Probucol for the Treatment of Diabetes
Patent: 8,252,840 →
Application: 12/055,926 →
Publication: US 2008/0280979
Compounds and Methods for the Inhibition of the Expression of VCAM-1
Application: 12/121,464 →
Publication: US 2008/0214660
Sulfonamide Containing Compounds for Treatment of Inflammatory Disorders
Patent: 7,897,776 →
Application: 12/148,966 →
Publication: US 2009/0270454
Spiro compounds for treatment of inflammatory disorders
Application: 12/151,919 →
Publication: US 2008/0280974
Process for the Separation of Probucol Derivatives
Application: 12/728,665 →
Publication: US 2010/0174108
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 2000
From: MEDFORD, RUSSELL M.; SAXENA, UDAY
To: ATHEROGENICS, INC.
Reel/Frame 010483/0751 →
Assignment of Assignor's Interest Feb 26, 2002
From: HOONG, LEE K.; MENG, CHARLES Q.; NI, LIMING; SIKORSKI, JAMES A.
To: ATHEROGENICS, INC.
Reel/Frame 012648/0977 →
Assignment of Assignor's Interest Feb 26, 2002
From: MEDFORD, RUSSELL M.; SAXENA, UDAY; HOONG, LEE K.; SOMERS, PATRICIA K.
To: ATHEROGENICS, INC.
Reel/Frame 012649/0714 →
Assignment of Assignor's Interest Feb 28, 2002
From: SOMERS, PATRICIA K.; HOONG, LEE, K.; SIKORSKI, JAMES A.; MENG, CHARLES Q.
To: ATHEROGENICS, INC.
Reel/Frame 012695/0095 →
Assignment of Assignor's Interest Feb 28, 2002
From: LUCHOOMUN, JAYRAZ; MENG, CHARLES Q.; SAXENA, UDAY; SIKORSKI, JAMES A.
To: ATHEROGENICS, INC.
Reel/Frame 012682/0580 →
Assignment of Assignor's Interest Apr 15, 2002
From: GLASS, MITCHELL; EDWARDS, DAVID B.; SOMERS, PATRICIA K.
To: ATHEROGENICS, INC.
Reel/Frame 012843/0831 →
Assignment of Assignor's Interest Jan 21, 2003
From: KUNSCH, CHARLES; VARNER, SIGNE E.; CHEN, XILIN; LUCHOOMUN, JAYRAZ
To: ATHEROGENICS, INC.
Reel/Frame 013760/0187 →
Change of Name Sep 3, 2010
From: CRABTREE ACQUISITION CO, LLC
To: SALUTRIA PHARMACEUTICALS LLC
Reel/Frame 024933/0651 →